| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |